Autoimmune/inflammatory syndrome induced by adjuvants (ASIA), medical treatment of severe systemic compromise: case report
Fuente:
Redalyc
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Artículo científico |
| Lenguaje: | en |
| Publicado: |
Universidad del Valle
2023
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1876479435651153920 |
|---|---|
| author | Germán Eduardo Puerta Sarmiento |
| author_facet | Germán Eduardo Puerta Sarmiento |
| contents | Autoimmune/inflammatory syndrome induced by adjuvants (ASIA), medical treatment of severe systemic compromise: case report Germán Eduardo Puerta Sarmiento Inés Modragón Alex Echeverri Luz Fernanda Sua Fabio Bonilla-Abadía David Aguirre-Valencia Medicina ASIA silicone polymers siloxanes biopolymers Case description: A 42-year-old woman with severe pulmonary and mediastinal inflammatory involvement, secondary to infiltration of a silicone-related allogenic material with systemic migration.Clinical findings: The patient developed esophageal and bronchial stenosis, recurrent infections, malnutrition, and respiratory deterioration, making surgical removal of the allogenic material impossible.Treatment and outcome: Clinical and radiological improvement was achieved after treatment with multiple intravenous and oral immunomodulators.Clinical relevance: Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) is a heterogeneous disease resulting from exposure to allogenic substances in a susceptible subject. These substances cause autoimmune or autoinflammatory phenomena. Since ASIA was described ten years ago, its diagnostic criteria are still under discussion, with an uncertain prognosis. The ideal therapy is based on eliminating the causative substance, but this is not always possible. Therefore, it is necessary to start an immunomodulatory treatment, using it in this patient, a scheme that had not been previously reported in the literature. 2023 otro 0120-8322 https://www.redalyc.org/articulo.oa?id=28375672005 https://www.redalyc.org/journal/283/28375672005/ https://www.redalyc.org/journal/283/28375672005/html/ https://www.redalyc.org/journal/283/28375672005/28375672005.epub https://www.redalyc.org/journal/283/28375672005/movil https://doi.org/10.25100/cm.v54i1.4625 en http://www.redalyc.org/revista.oa?id=283 Colombia Médica application/pdf Universidad del Valle Colombia Médica (Colombia) Num.1 Vol.54 |
| format | Artículo científico |
| id | redalyc_28375672005 |
| institution | Redalyc |
| language | en |
| publishDate | 2023 |
| publisher | Universidad del Valle |
| spellingShingle | Autoimmune/inflammatory syndrome induced by adjuvants (ASIA), medical treatment of severe systemic compromise: case report Germán Eduardo Puerta Sarmiento Medicina ASIA silicone polymers siloxanes biopolymers Autoimmune/inflammatory syndrome induced by adjuvants (ASIA), medical treatment of severe systemic compromise: case report Germán Eduardo Puerta Sarmiento Inés Modragón Alex Echeverri Luz Fernanda Sua Fabio Bonilla-Abadía David Aguirre-Valencia Medicina ASIA silicone polymers siloxanes biopolymers Case description: A 42-year-old woman with severe pulmonary and mediastinal inflammatory involvement, secondary to infiltration of a silicone-related allogenic material with systemic migration.Clinical findings: The patient developed esophageal and bronchial stenosis, recurrent infections, malnutrition, and respiratory deterioration, making surgical removal of the allogenic material impossible.Treatment and outcome: Clinical and radiological improvement was achieved after treatment with multiple intravenous and oral immunomodulators.Clinical relevance: Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) is a heterogeneous disease resulting from exposure to allogenic substances in a susceptible subject. These substances cause autoimmune or autoinflammatory phenomena. Since ASIA was described ten years ago, its diagnostic criteria are still under discussion, with an uncertain prognosis. The ideal therapy is based on eliminating the causative substance, but this is not always possible. Therefore, it is necessary to start an immunomodulatory treatment, using it in this patient, a scheme that had not been previously reported in the literature. 2023 otro 0120-8322 https://www.redalyc.org/articulo.oa?id=28375672005 https://www.redalyc.org/journal/283/28375672005/ https://www.redalyc.org/journal/283/28375672005/html/ https://www.redalyc.org/journal/283/28375672005/28375672005.epub https://www.redalyc.org/journal/283/28375672005/movil https://doi.org/10.25100/cm.v54i1.4625 en http://www.redalyc.org/revista.oa?id=283 Colombia Médica application/pdf Universidad del Valle Colombia Médica (Colombia) Num.1 Vol.54 |
| title | Autoimmune/inflammatory syndrome induced by adjuvants (ASIA), medical treatment of severe systemic compromise: case report |
| topic | Medicina ASIA silicone polymers siloxanes biopolymers |
| url | https://www.redalyc.org/articulo.oa?id=28375672005 https://www.redalyc.org/journal/283/28375672005/ https://www.redalyc.org/journal/283/28375672005/html/ https://www.redalyc.org/journal/283/28375672005/28375672005.epub https://www.redalyc.org/journal/283/28375672005/movil https://doi.org/10.25100/cm.v54i1.4625 |